Smith & Nephew (NYSE:SNN) Rating Lowered to Hold at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew (NYSE:SNN) from a buy rating to a hold rating in a report released on Friday morning, MarketBeat Ratings reports.

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th.

Smith & Nephew Price Performance

Shares of NYSE:SNN opened at $25.28 on Friday. Smith & Nephew has a 12 month low of $23.65 and a 12 month high of $31.72. The firm has a market capitalization of $11.05 billion, a P/E ratio of 12.70, a P/E/G ratio of 1.10 and a beta of 0.85. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The company’s fifty day moving average price is $29.87 and its 200 day moving average price is $27.85.

Institutional Trading of Smith & Nephew

Several institutional investors and hedge funds have recently bought and sold shares of the business. Argonautica Private Wealth Management Inc. raised its stake in Smith & Nephew by 6.3% during the 2nd quarter. Argonautica Private Wealth Management Inc. now owns 10,244 shares of the medical equipment provider’s stock valued at $254,000 after acquiring an additional 605 shares during the last quarter. First Trust Direct Indexing L.P. raised its stake in shares of Smith & Nephew by 6.9% during the third quarter. First Trust Direct Indexing L.P. now owns 9,659 shares of the medical equipment provider’s stock worth $301,000 after purchasing an additional 626 shares during the last quarter. Inspire Advisors LLC lifted its holdings in shares of Smith & Nephew by 3.0% during the second quarter. Inspire Advisors LLC now owns 22,286 shares of the medical equipment provider’s stock worth $552,000 after purchasing an additional 639 shares during the period. Rhumbline Advisers grew its position in Smith & Nephew by 8.6% in the 2nd quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock valued at $257,000 after buying an additional 819 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in Smith & Nephew by 13.8% in the 1st quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock valued at $244,000 after buying an additional 1,165 shares during the period. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.